Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Research Area(s) / Expertise: Job title: Director
Dr Claudio Tondo is the Chairman of the Heart Rhythm centre at Centro Cardiologico, University of Milan, Italy. Dr Tondo's interests range from clinical aspects of arrhythmias to genetics. View more
Foreword

Article

Author(s): Simon Kennon Added: 3 years ago
The key aim of this journal is to provide up to date and detailed review of data relating to problems commonly encountered by cardiologists. This issue of Interventional Cardiology Review deals with a wide spectrum of such problems. There are four articles that relate to our concerns about thrombus and bleeding in the context of coronary intervention. The effect of bleeding on outcomes following… View more
Author(s): Ole De Backer , Darren Mylotte , Colum Owens , et al Added: 2 years ago
In this symposium, part of Transcatheter Interventions Online 2022, Dr Colum Owens and Prof Mark Spence from Royal Victoria Hospital, Belfast perform a TAVI implantation with a focus on preserving future coronary access. Before the live case, Prof Ole De Backer and Dr Darren Mylotte will present on current trends in TAVI and key considerations for first choice valve in low-risk populations. … View more
Author(s): Satinder K Sandhu Added: 3 years ago
Over the last three decades numerous transcatheter therapies for the treatment of congenital heart disease (CHD) have been developed. Interatrial Septal Defect Balloon atrial septostomy has been performed in patients with transposition physiology and in patients where egress of blood is needed from the left or the right atrium and in adults with pulmonary vascular disease where the creation of… View more
Author(s): Pascal Thériault-Lauzier , Marco Spaziano , Beatriz Vaquerizo , et al Added: 3 years ago
Valvular Disease Aortic valve Severe symptomatic aortic stenosis (AS) bears a dismal prognosis. The mean survival is 2.0 to 4.7 years after the onset of angina, 0.8 to 3.8 years after the onset of syncope and 0.5 to 2.8 years after the onset of congestive heart failure.1 Surgical aortic valve replacement (SAVR) is the mainstay of treatment for these patients.2 In the last decade transcatheter… View more
Author(s): Amar Krishnaswamy , Emin Murat Tuzcu , Samir R Kapadia Added: 3 years ago
Among patients undergoing surgical valve replacement, 1–5 % of patients with an aortic valve replacement (AVR) and 2–12 % with a mitral valve replacement (MVR) may develop paravalvular regurgitation or ‘leak’ (PVL).1–3 In the era of transcatheter aortic valve replacement (TAVR) with first-generation balloon expandable valves, up to 17 % of patients may be left with moderate or severe PVL, also… View more
Author(s): Mohamed Abdel-Wahab Added: 2 years ago
In this short summary interview, Dr Mohamed Abdel-Wahab (Heart Center Leipzig, University of Leipzig, DE) talks about the findings of the CHOICE-CLOSURE trial. The randomized trial investigated the plug-based versus suture-based large-bore vascular closure. Discussion points: 1. Importance of this study 2. Study design and patient cohort 3. Key findings 4. Impact on practice 5. Next steps … View more